Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy

Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy

Moraxella catarrhalis is not commonly associated with prosthetic joint infection (PJI). We present the first case of a patient with rheumatoid arthritis on certolizumab, an anti-tumor necrosis factor therapy, who developed PJI following a total knee replacement.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of the NYU Hospital for Joint Diseases 2017-04, Vol.75 (2), p.140
Hauptverfasser: Evangelista, Perry J, Evangelista, Gregory T, Ogrich, Lauren M
Format: Artikel
Sprache:eng
Schlagworte:
Antirheumatic agents
Branhamella catarrhalis
Complications and side effects
Gram-negative bacterial infections
Health aspects
Infections
Joint replacement surgery
Knee
Monoclonal antibodies
Patient outcomes
Physiological aspects
Rheumatoid arthritis
Risk factors
Tumor necrosis factor-TNF
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Moraxella catarrhalis is not commonly associated with prosthetic joint infection (PJI). We present the first case of a patient with rheumatoid arthritis on certolizumab, an anti-tumor necrosis factor therapy, who developed PJI following a total knee replacement.
ISSN:1936-9719
1936-9727